News

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...
Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
It’s a disease that not many know about, despite estimates indicating that India carries the second-highest burden globally. Sickle cell disease, a group of inherited blood disorders, affects ...